SELLAS Life Sciences Group (SLS) Other Non-Current Liabilities: 2011-2022
Historic Other Non-Current Liabilities for SELLAS Life Sciences Group (SLS) over the last 7 years, with Sep 2022 value amounting to $170,000.
- SELLAS Life Sciences Group's Other Non-Current Liabilities fell 96.62% to $170,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $170,000, marking a year-over-year decrease of 96.62%. This contributed to the annual value of $296,000 for FY2021, which is 93.61% down from last year.
- Per SELLAS Life Sciences Group's latest filing, its Other Non-Current Liabilities stood at $170,000 for Q3 2022, which was down 6.08% from $181,000 recorded in Q2 2022.
- In the past 5 years, SELLAS Life Sciences Group's Other Non-Current Liabilities ranged from a high of $5.2 million in Q2 2020 and a low of $170,000 during Q3 2022.
- In the last 3 years, SELLAS Life Sciences Group's Other Non-Current Liabilities had a median value of $4.8 million in 2021 and averaged $3.2 million.
- In the last 5 years, SELLAS Life Sciences Group's Other Non-Current Liabilities climbed by 8.01% in 2020 and then plummeted by 96.62% in 2022.
- SELLAS Life Sciences Group's Other Non-Current Liabilities (Quarterly) stood at $4.9 million in 2019, then declined by 5.68% to $4.6 million in 2020, then crashed by 93.61% to $296,000 in 2021, then crashed by 96.62% to $170,000 in 2022.
- Its Other Non-Current Liabilities was $170,000 in Q3 2022, compared to $181,000 in Q2 2022 and $296,000 in Q1 2022.